Opendata, web and dolomites

PREKIND

PreEclampsia diagnosis by Early Kidney Injury Detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREKIND project word cloud

Explore the words cloud of the PREKIND project. It provides you a very rough idea of what is the project "PREKIND" about.

demonstrated    risk    introduction    feasibility    budgets    assays    mayo    urine    renal    ruo    http    solutions    life    deaths    annual    podocyte    spend    leader    preelampsia    indicate    predict    business    elisa    plan    flow    specificity    clinical    usa    500    conduct    clinic    syndrome    diagnostic    preeclampsia    cytometry    innovative    claims    surviving    millions    alone    vesna    provision    health    prognostic    women    licensed    care    exceptional    rest    complications    develops    months    infant    diagnose    symptoms    ongoing    damage    disease    ib    too    accounts    sub    world    7billion    31billion    diagnosis    75    year1    org    emerge3    variety    dr    sensitivity    annually    innovation    biomarker    cardiovascular    foundation    pe    informbio    pregnant    000    pioneering    garovic    worldwide    ambition    dealing    pregnancy    antenatal    mothers    contribution    estimates    biomarkers    tests    lives    babies    podocin    survive    form    direct   

Project "PREKIND" data sheet

The following table provides information about the project.

Coordinator
INFORM BIOSCIENCE LIMITED 

Organization address
address: HOFFMAN PARK LITTLE ISLAND COUNTY CORK
city: CORK
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.informbio.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFORM BIOSCIENCE LIMITED IE (CORK) coordinator 50˙000.00

Map

 Project objective

Health Challenge: PreEclampsia (PE) claims the lives of 75,000 women annually and the 6,000,000 surviving mothers will have an increased risk of cardiovascular disease for the rest of their life. PE accounts for over 500,000 infant deaths worldwide every year1; and for the millions of babies that survive, they too will go on to have increased risk of a variety of health issues. PE is a syndrome that develops during pregnancy but presents no clinical symptoms during most of the pregnancy and is therefore currently complex to diagnose. Business Challenge: With an annual spend of over 31Billion in direct costs in the developed world alone, the provision of antenatal care to pregnant women has a significant impact on health care budgets; dealing with the immediate consequences of PE form an important contribution to this cost. The Preelampsia foundation (http://www.preeclampsia.org/) estimates the annual cost of PE is more than $7billion in the US. InformBio Business Innovation: InformBio (IB) has licensed pioneering research by Dr.Vesna Garovic of the Mayo Clinic, USA. The technology has identified podocyte specific biomarkers in urine that indicate ongoing renal damage and which allow for a sub-clinical diagnosis for PE. The key biomarker, podocin, has demonstrated exceptional sensitivity and specificity and can diagnose the disease up to 3 months before clinical symptoms emerge3. InformBio are currently working to develop flow cytometry and research use only (RUO) ELISA assays for the biomarker. InformBio’s ambition is to be the world leader in early pregnancy prognostic tests, offering the most innovative, cost effective solutions to predict pregnancy complications.

Phase 1 proposal: To conduct a feasibility study to support the development of a detailed business plan for the introduction of a PE diagnostic test.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREKIND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREKIND" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More